Direct and indirect costs associated with moderate and severe asthma in Quebec, Canada

References

• GBD 2015 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388(10053):1545–1602. doi: 10.1016/S0140-6736(16)31678-6
   PubMed Web of Science ®Google Scholar
• Statistics Canada. Asthma 2014. 2014. http://www.statcan.gc.ca/pub/82-625-x/2015001/article/14179-eng.htm. Accessed May 18, 2017.
   Google Scholar
• Global Initiative for Asthma. Global strategy for asthma management and prevention. http://ginasthmaorg/gina-reports/. 2017.
   Google Scholar
• Sadatsafavi M, Lynd L, Marra C, Carleton B, et al. Direct health care costs associated with asthma in British Columbia. Can Respir J. 2010;17(2):74–80. doi: 10.1155/2010/361071
   PubMed Web of Science ®Google Scholar
• Hermus G, Stonebridge C, Goldfarb D, Theriault L, Bounajm F. Cost Risk Analysis for Chronic Lung Disease in Canada: The Conference Board of Canada, 2012.
   Google Scholar
• Guilbert TW, Garris C, Jhingran P, Bonafede M, et al. Asthma that is not well-controlled is associated with increased healthcare utilization and decreased quality of life. J Asthma. 2011;48(2):126–132. doi: 10.3109/02770903.2010.535879
   PubMed Web of Science ®Google Scholar
• Griswold SK, Nordstrom CR, Clark S, Gaeta TJ, Price ML, Camargo CA. Jr., Asthma exacerbations in North American adults: who are the “frequent fliers” in the emergency department? Chest. 2005;127(5):1579–1586. doi: 10.1378/chest.127.5.1579
   PubMed Web of Science ®Google Scholar
• Ivanova JI, Bergman R, Birnbaum HG, Colice GL, Silverman RA, McLaurin K. Effect of asthma exacerbations on health care costs among asthmatic patients with moderate and severe persistent asthma. J Allergy Clin Immunol. 2012;129(5):1229–1235. doi: 10.1016/j.jaci.2012.01.039
   PubMed Web of Science ®Google Scholar
• Zeiger RS, Schatz M, Dalal AA, Qian L, et al. Utilization and costs of severe uncontrolled asthma in a managed-care setting. J Allergy Clin Immunol Pract. 2016;4(1):120–129.e3. doi: 10.1016/j.jaip.2015.08.003
   PubMed Web of Science ®Google Scholar
• Accordini S, Corsico AG, Braggion M, Gerbase MW, et al. The cost of persistent asthma in Europe: an international population-based study in adults. Int Arch Allergy Immunol. 2013;160(1):93–101. doi: 10.1159/000338998
   PubMed Web of Science ®Google Scholar
• GlaxoSmithKline. Direct Cost of Illness Study of Moderate and Severe Asthma in Quebec. 2015. https://www.gsk-clinicalstudyregister.com/study/200346. Accessed July 20, 2017.
   Google Scholar
• GlaxoSmithKline. Indirect cost of illness study of moderate and severe asthma in Quebec. 2017. https://www.gsk-clinicalstudyregister.com/study/200347. Accessed July 20, 2017.
   Google Scholar
• Blais L. REMED: DATA REGISTRY FOR PRESCRIBED MEDICATIONS. 2016. http://www.rqrm.ca/plateformes/optimisation-de-l-usage/64-4-remed-data-registry-for-prescribed-medications-banque-de-donnees-sur-les-medicaments-d-ordonnance.html. Accessed June 7, 2017.
   Google Scholar
• Juniper EF, O'Byrne PM, Guyatt GH, Ferrie PJ, King DR. Development and validation of a questionnaire to measure asthma control. Eur Respir J. 1999;14(4):902–907. doi: 10.1034/j.1399-3003.1999.14d29.x
   PubMed Web of Science ®Google Scholar
• Romano PS, Roos LL, Jollis JG. Adapting a clinical comorbidity index for use with ICD-9-CM administrative data: differing perspectives. J Clin Epidemiol. 1993;46(10):1075–1079. discussion 81-90. doi: 10.1016/0895-4356(93)90103-8
   PubMed Web of Science ®Google Scholar
• Schneeweiss S, Wang PS, Avorn J, Glynn RJ. Improved comorbidity adjustment for predicting mortality in Medicare populations. Health Serv Res. 2003;38(4):1103–1120. doi: 10.1111/1475-6773.00165
   PubMed Web of Science ®Google Scholar
• Reilly MC, Zbrozek AS, Dukes EM. The validity and reproducibility of a work productivity and activity impairment instrument. Pharmacoeconomics 1993;4(5):353–365. doi: 10.2165/00019053-199304050-00006
   PubMed Web of Science ®Google Scholar
• Zhang W, Bansback N, Boonen A, Severens JL, Anis AH. Development of a composite questionnaire, the valuation of lost productivity, to value productivity losses: application in rheumatoid arthritis. Value Health. 2012;15(1):46–54. doi: 10.1016/j.jval.2011.07.009
   PubMed Web of Science ®Google Scholar
• Zhang W, Bansback N, Kopec J, Anis AH. Measuring time input loss among patients with rheumatoid arthritis: validity and reliability of the Valuation of Lost Productivity questionnaire. J Occup Environ Med. 2011;53(5):530–536. doi: 10.1097/JOM.0b013e318218abf1
   Web of Science ®Google Scholar
• Cisternas MG, Blanc PD, Yen IH, Katz PP, et al. A comprehensive study of the direct and indirect costs of adult asthma. J Allergy Clin Immunol. 2003;111(6):1212–1218. doi: 10.1067/mai.2003.1449
   PubMed Web of Science ®Google Scholar
• Krahn M. Cost-effectiveness analysis: are the outputs worth the inputs? ACP J Club. 1996;124(3):82. doi: 10.7326/ACPJC-1996-124-1-A12
   Google Scholar
• Ismaila AS, Sayani AP, Marin M, Su Z. Clinical, economic, and humanistic burden of asthma in Canada: a systematic review. BMC Pulm Med. 2013;13:70. doi: 10.1186/1471-2466-13-70
   PubMed Web of Science ®Google Scholar
• Suruki RY, Daugherty JB, Boudiaf N, Albers FC. The frequency of asthma exacerbations and healthcare utilization in patients with asthma from the UK and USA. BMC Pulm Med. 2017;17(1):74. doi: 10.1186/s12890-017-0409-3
   PubMed Web of Science ®Google Scholar
• Lougheed MD, Lemiere C, Ducharme FM, et al. Canadian Thoracic Society 2012 guideline update: diagnosis and management of asthma in preschoolers, children and adults: executive summary. Can Respir J. 2012;19(6):e81–e88. doi: 10.1155/2012/214129
   PubMedGoogle Scholar
• Novartis Pharmaceuticals Canada Inc. Product Monograph XOLAIR® (omalizumab). 2015. https://www.novartis.ca/sites/www.novartis.ca/files/xolair_scrip_e.pdf. Accessed August 2018.
   Google Scholar
• Bedouch P, Sadatsafavi M, Marra CA, FitzGerald JM, Lynd LD. Trends in asthma-related direct medical costs from 2002 to 2007 in British Columbia, Canada: a population based-cohort study. PLoS One. 2012;7(12):e50949. doi: 10.1371/journal.pone.0050949
   Web of Science ®Google Scholar
• Seung SJ, Mittmann N. Urgent care costs of uncontrolled asthma in Canada, 2004. Can Respir J. 2005;12(8):435–436. doi: 10.1155/2005/478764
   Google Scholar
• Thanh NX, Ohinmaa A, Yan C. Asthma-related productivity losses in Alberta, Canada. J Asthma Allergy. 2009;2:43–48.
   Google Scholar
• Antonicelli L, Bucca C, Neri M, De Benedetto F, et al. Asthma severity and medical resource utilisation. Eur Respir J. 2004;23(5):723–729. doi: 10.1183/09031936.04.00004904
   PubMed Web of Science ®Google Scholar